Skip to main content
Calliditas Therapeutics AB (publ) (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
22.19
+0.29 (1.32%)
At close: May 17, 2024, 11:17 AM
21.26
-0.93 (-4.19%)
After-hours: May 17, 2024, 4:06 PM EDT

CALT Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Revenue
1,207802.88229.350.87184.830
Revenue Growth (YoY)
50.32%250.07%26141.08%-99.53%--
Cost of Revenue
60.4615.20000
Gross Profit
1,146787.68229.350.87184.830
Selling, General & Admin
1,061774.66390.23141.7262.8831.13
Research & Development
502.22414.75357.49241.37149.8399.26
Other Operating Expenses
-43.4720.216.09-2.50.142.09
Operating Expenses
1,5191,210753.8380.59212.85132.48
Operating Income
-373.06-421.94-524.46-379.72-28.02-132.48
Interest Expense / Income
114.3537.679.2556.985.410.01
Other Expense / Income
-30.39-50.19-29.58-3.56-0.93-0.44
Pretax Income
-457.02-409.42-504.13-433.13-32.5-132.05
Income Tax
9.172.85-3.840.360.080
Net Income
-466.19-412.27-500.29-433.49-32.58-132.05
Shares Outstanding (Basic)
6059504646-
Shares Change
0.80%18.35%7.88%---
EPS (Basic)
-17.38-15.56-19.68-19.32-1.76-10.18
EPS (Diluted)
-17.38-15.56-19.68-19.32-1.76-10.18
Free Cash Flow
-447.44-313.87-468.18-309.18-71.13-128.19
Free Cash Flow Per Share
-15.02-10.62-18.75-13.36-3.07-
Gross Margin
94.99%98.11%100.00%100.00%100.00%-
Operating Margin
-30.91%-52.55%-228.67%-43446.22%-15.16%-
Profit Margin
-38.63%-51.35%-218.14%-49598.86%-17.63%-
Free Cash Flow Margin
-37.07%-39.09%-204.13%-35375.40%-38.48%-
EBITDA
-342.67-371.75-494.88-376.16-27.09-132.04
EBITDA Margin
-28.39%-46.30%-215.78%-43038.44%-14.66%-
EBIT
-342.67-371.75-494.88-376.16-27.09-132.04
EBIT Margin
-28.39%-46.30%-215.78%-43038.44%-14.66%-
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).